AAAAAA

   
Results: 1-12 |
Results: 12
ROPINIROLE FOR THE TREATMENT OF EARLYPARKINSON-DISEASE - A 12-MONTH EXPERIENCE
Authors: SETHI KD OBRIEN CF HAMMERSTAD JP ADLER CH DAVIS TL TAYLOR RL SANCHEZRAMOS J BERTONI JM HAUSER RA
Citation: Kd. Sethi et al., ROPINIROLE FOR THE TREATMENT OF EARLYPARKINSON-DISEASE - A 12-MONTH EXPERIENCE, Archives of neurology, 55(9), 1998, pp. 1211-1216
FLUOXETINE-INDUCED MOVEMENT-DISORDERS AND DEFICIENT CYP2D6 ENZYME-ACTIVITY - REPLY
Authors: BHARUCHA KJ SETHI KD
Citation: Kj. Bharucha et Kd. Sethi, FLUOXETINE-INDUCED MOVEMENT-DISORDERS AND DEFICIENT CYP2D6 ENZYME-ACTIVITY - REPLY, Movement disorders, 12(4), 1997, pp. 624-625
AN OPEN-LABEL STUDY OF BOTULINUM TOXIN-A FOR TREATMENT OF TARDIVE-DYSTONIA
Authors: TARSY D KAUFMAN D SETHI KD RIVNER MH MOLHO E FACTOR S
Citation: D. Tarsy et al., AN OPEN-LABEL STUDY OF BOTULINUM TOXIN-A FOR TREATMENT OF TARDIVE-DYSTONIA, Clinical neuropharmacology, 20(1), 1997, pp. 90-93
ROPINIROLE FOR THE TREATMENT OF EARLY PARKINSONS-DISEASE
Authors: ADLER CH SETHI KD HAUSER RA DAVIS TL HAMMERSTAD JP BERTONI J TAYLOR RL SANCHEZRAMOS J OBRIEN CF
Citation: Ch. Adler et al., ROPINIROLE FOR THE TREATMENT OF EARLY PARKINSONS-DISEASE, Neurology, 49(2), 1997, pp. 393-399
SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE
Authors: RICHARD IH KURLAN R TANNER C FACTOR S HUBBLE J SUCHOWERSKY O WATERS C GOETZ C JUNCOS JL STERN M HARRISON MB SETHI KD STANDAERT D TROSCH R REICH S KIEBURTZ K FEIGIN A MARSHALL FJ GAUTHIER S PANISSET M LEW ME FRIEDMAN JH PAULSON G RODNITZKY RL HAUSER R KURTH M HURTIG H THAL L ELMER LW PERLMUTTER JS GOLBE LI COMELLA C LANG A MARK MH SINGER C SHOULSON I WEINER WJ PFEIFFER R MAREK KL NUTT J WOOTEN GF JANKOVIC J LEWITT P HOEHN M BENNETT J PARSA M KOLLER W
Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077
BOTULINUM TOXIN-A (BOTOX) THERAPY DURING PREGNANCY
Authors: MOSER E LIGON KM SINGER C SETHI KD
Citation: E. Moser et al., BOTULINUM TOXIN-A (BOTOX) THERAPY DURING PREGNANCY, Neurology, 48(3), 1997, pp. 69008-69008
COMPLEX MOVEMENT-DISORDERS INDUCED BY FLUOXETINE
Authors: BHARUCHA KJ SETHI KD
Citation: Kj. Bharucha et Kd. Sethi, COMPLEX MOVEMENT-DISORDERS INDUCED BY FLUOXETINE, Movement disorders, 11(3), 1996, pp. 324-326
CLOZAPINE-INDUCED ASTERIXIS
Authors: BHARUCHA KJ ZAMRINI E EVANS D DURRELL D SETHI KD
Citation: Kj. Bharucha et al., CLOZAPINE-INDUCED ASTERIXIS, Neurology, 46(2), 1996, pp. 3123-3123
TARDIVE TOURETTISM AFTER EXPOSURE TO NEUROLEPTIC THERAPY
Authors: BHARUCHA KJ SETHI KD
Citation: Kj. Bharucha et Kd. Sethi, TARDIVE TOURETTISM AFTER EXPOSURE TO NEUROLEPTIC THERAPY, Movement disorders, 10(6), 1995, pp. 791-793
THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS -REPLY
Authors: HESS DC SETHI KD
Citation: Dc. Hess et Kd. Sethi, THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS -REPLY, Journal of rheumatology, 20(9), 1993, pp. 1626-1626
COGNITIVE AND NEUROLOGIC DEFICITS IN THE MRL LPR MOUSE - A CLINICOPATHOLOGICAL STUDY/
Authors: HESS DC TAORMINA M THOMPSON J SETHI KD DIAMOND B RAO R CHAMBERLAIN CR FELDMAN DS
Citation: Dc. Hess et al., COGNITIVE AND NEUROLOGIC DEFICITS IN THE MRL LPR MOUSE - A CLINICOPATHOLOGICAL STUDY/, Journal of rheumatology, 20(4), 1993, pp. 610-617
PAROXYSMAL HEMIDYSTONIA - EVIDENCE OF A MIDBRAIN LESION
Authors: SETHI KD
Citation: Kd. Sethi, PAROXYSMAL HEMIDYSTONIA - EVIDENCE OF A MIDBRAIN LESION, Neurology, 43(4), 1993, pp. 329-329
Risultati: 1-12 |